Cargando…
Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
BACKGROUND: Experimental animal data show that protection against severe acute respiratory syndrome coronavirus (SARS-CoV) infection with human monoclonal antibodies (mAbs) is feasible. For an effective immune prophylaxis in humans, broad coverage of different strains of SARS-CoV and control of pote...
Autores principales: | ter Meulen, Jan, van den Brink, Edward N, Poon, Leo L. M, Marissen, Wilfred E, Leung, Cynthia S. W, Cox, Freek, Cheung, Chung Y, Bakker, Arjen Q, Bogaards, Johannes A, van Deventer, Els, Preiser, Wolfgang, Doerr, Hans Wilhelm, Chow, Vincent T, de Kruif, John, Peiris, Joseph S. M, Goudsmit, Jaap |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1483912/ https://www.ncbi.nlm.nih.gov/pubmed/16796401 http://dx.doi.org/10.1371/journal.pmed.0030237 |
Ejemplares similares
-
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM(+) Memory B Cells
por: Throsby, Mark, et al.
Publicado: (2008) -
The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis()
por: Bogaards, Johannes Antonie, et al.
Publicado: (2007) -
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
por: ter Meulen, Jan, et al.
Publicado: (2004) -
Human monoclonal antibodies for prophylaxis and therapy of viral infections
por: Meulen, Jan ter, et al.
Publicado: (2006) -
The Human Antibody Response Against WNV
por: Throsby, Mark, et al.
Publicado: (2009)